Mobix Labs and Peraso entered into a mutual confidentiality agreement on November 3, 2025, to begin structured discussions about a potential acquisition. The agreement follows Mobix’s unsolicited offer to acquire Peraso in June 2025 and replaces earlier exploratory efforts.
The confidentiality agreement establishes a framework for exchanging confidential information and evaluating synergies between Peraso’s millimeter‑wave (mmWave) technology and Mobix’s high‑reliability connectivity solutions. Peraso’s mmWave platform supports 5G, fixed wireless access, aerospace, and defense applications, while Mobix specializes in RF, interconnect, and filtering solutions for defense and aerospace markets.
If the parties reach a transaction, the combined company would combine Peraso’s stealthy beamforming and fiber‑like speeds with Mobix’s AI‑driven power‑aware radio architectures, targeting the AI energy infrastructure market and expanding Mobix’s product portfolio. The deal would also help Peraso meet Nasdaq listing requirements and provide a stable platform for its shareholders.
Peraso reported first‑quarter 2025 revenue of $3.8 million and full‑year 2024 revenue of $14.2 million, with a negative EBITDA of $5.99 million in the last twelve months. Mobix Labs had trailing‑12‑month revenue of $10.98 million and a net loss of $41.94 million, and a market capitalization of $43.23 million. The financial data underscore the strategic rationale for the potential combination.
Mobix has made multiple offers for Peraso, including a stock‑for‑stock proposal in June 2025, an enhanced cash‑and‑stock proposal in September 2025, and an all‑cash offer of $1.30 per share in October 2025. The current confidentiality agreement marks a progression toward a definitive transaction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.